Annalisa Jenkins is a biotech CEO. She had excellent training. She’s a scientist. She was a senior vice president of R&D, and an executive vice president of R&D, at two major drugmakers. She was once the only woman serving on a British naval ship in the Persian Gulf with 700 men.
Everywhere she goes on the biotech fundraising circuit, she stands out. When she describes her vision for Dimension Therapeutics, a gene therapy company, it’s almost always to rooms full of men in dark suits.
